Primary Site >> Esophagus Cancer

Gene >> SLC22A2

Journal: Oncol Lett. 2013 Feb;5(2):427-434. Epub 2012 Nov 5.
Title: Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin.
Author: Minegaki, Tetsuya|Takara, Kohji|Hamaguchi, Ryohei|Tsujimoto, Masayuki|Nishiguchi, Kohshi
PMID: 23420099
Journal: Eur J Pharm Sci. 2016 Jan 1;81:137-48.
Title: Celecoxib antagonizes the cytotoxicity of oxaliplatin in human esophageal cancer cells by impairing the drug influx.
Author: Kong, Yi|Gu, Chunping|Zhong, Desheng|Zhao, Xuyan|Lin, Qinghuan|Wang, Keng|Xun, Tianrong|Yu, Le|Liu, Shuwen
PMID: 26474693
Journal: Cancer Chemother Pharmacol. 2017 May;79(5):943-949.
Title: Co-administration of proton pump inhibitors ameliorates nephrotoxicity in patients receiving chemotherapy with cisplatin and fluorouracil: a retrospective cohort study.
Author: Ikemura, Kenji|Oshima, Kosuke|Enokiya, Tomoyuki|Okamoto, Akiharu|Oda, Hiroyasu|Mizuno, Toshiro|Ishinaga, Hajime|Muraki, Yuichi|Iwamoto, Takuya|Takeuchi, Kazuhiko|Katayama, Naoyuki|Okuda, Masahiro
PMID: 28364288